Bio-Sig-Logo-horiz.jpg
BioSig Sees Increased Case Volume from Expanding Base of Medical Centers Using Its Proprietary Signal Processing System
May 04, 2021 09:15 ET | BioSig Technologies, Inc.
Westport, CT, May 04, 2021 (GLOBE NEWSWIRE) -- The Company sees increased technology usage across its installed base and anticipates enrolling to at least 1500 cases by the end of 2021 44 physicians...
Bio-Sig-Logo-horiz.jpg
BioSig Technologies, Inc. Invited to Present at Wall Street Conference
May 03, 2021 12:00 ET | BioSig Technologies, Inc.
Westport, CT, May 03, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing...
Bio-Sig-Logo-horiz.jpg
BioSig’s PURE EP(tm) System Evaluated with Patients at Mayo Clinic in Arizona
April 27, 2021 09:30 ET | BioSig Technologies, Inc.
Westport, CT, April 27, 2021 (GLOBE NEWSWIRE) -- The clinic is conducting an evaluation of the PURE EP(tm) System, a signal processing technology for cardiac arrhythmia treatmentsNew installation...
Bio-Sig-Logo-horiz.jpg
BioSig Expands Commercial Team in Two Strategic Regions
April 15, 2021 11:45 ET | BioSig Technologies, Inc.
Westport, CT, April 15, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing...
Bio-Sig-Logo-horiz.jpg
BioSig Launches Enhanced Signal Processing Capabilities for Advanced Cardiac Signal Analysis Through its Electrophysiology Platform
April 14, 2021 09:29 ET | BioSig Technologies, Inc.
Westport, CT, April 14, 2021 (GLOBE NEWSWIRE) -- The latest release represents the most advanced software version of the PURE EPTM System, signal processing technology for treatments of irregular...
Bio-Sig-Logo-horiz.jpg
BioSig Completes Enrollment in the PURE EP 2.0 Clinical Study
April 13, 2021 09:32 ET | BioSig Technologies, Inc.
Westport, CT, April 13, 2021 (GLOBE NEWSWIRE) -- 51 patients undergoing elective cardiac ablation treatments were enrolled in the trial at Mayo Clinic, Massachusetts General Hospital, and St....
Bio-Sig-Logo-horiz.jpg
BioSig Invited to Join Alliance for Artificial Intelligence in Healthcare (AAIH)
April 09, 2021 09:32 ET | BioSig Technologies, Inc.
Westport, CT, April 09, 2021 (GLOBE NEWSWIRE) -- Global leaders, including Amazon, Bayer, and GE Healthcare, joined the AAIH to date to collaborate on developing novel solutions to improve the...
Bio-Sig-Logo-horiz.jpg
EP Lab Digest Features Physician Experience with BioSig’s Cardiac Signal Acquisition Technology
April 08, 2021 09:32 ET | BioSig Technologies, Inc.
Westport, CT, April 08, 2021 (GLOBE NEWSWIRE) -- Leading industry publication highlights the rising importance of intracardiac signals in complex cardiac ablations that treat irregular heart rhythm...
Bio-Sig-Logo-horiz.jpg
BioSig lands Commercial Sales to Leading Hospital System
April 06, 2021 09:45 ET | BioSig Technologies, Inc.
Westport, CT, April 06, 2021 (GLOBE NEWSWIRE) -- World class healthcare institution adopts PURE EP™  across multiple StatesMedical centers resuming elective procedures helps drive sales acceleration...
Bio-Sig-Logo-horiz.jpg
BioSig Technologies, Inc. to Present at the 20th Annual Needham Virtual Healthcare Conference
April 05, 2021 10:00 ET | BioSig Technologies, Inc.
Westport, CT, April 05, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...